A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder

BACKGROUND: Buprenorphine treatment is not equally effective in all patients with opioid use disorder (OUD). Two retrospective studies showed that, among African Americans (AAs), rs678849, a polymorphism in the delta-opioid receptor gene, moderated the therapeutic effect of sublingual buprenorphine....

Descripción completa

Detalles Bibliográficos
Autores principales: Kranzler, Henry R, Lynch, Kevin G, Crist, Richard C, Hartwell, Emily, Le Moigne, Anne, Laffont, Celine M, Andorn, Anne C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Regular Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883889/
https://www.ncbi.nlm.nih.gov/pubmed/32920647
http://dx.doi.org/10.1093/ijnp/pyaa069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883889/
https://www.ncbi.nlm.nih.gov/pubmed/32920647
http://dx.doi.org/10.1093/ijnp/pyaa069

Ejemplares similares